Recruiting Studies
Advanced SearchData: ClinicalTrials.gov · Source of record for eligibility and locations
Top Cities for Myalgic Encephalomyelitis Clinical Trials
Myalgic Encephalomyelitis clinical trials are recruiting across 199 cities. Here are the cities with the most active studies:
Myalgic Encephalomyelitis Trial Phases
89 research organizations are sponsoring myalgic encephalomyelitis trials.
About Myalgic Encephalomyelitis
Myalgic encephalomyelitis (ME/CFS) is a complex, chronic illness characterized by profound fatigue, post-exertional malaise, cognitive impairment, and sleep dysfunction. It affects millions worldwide and has no definitive diagnostic test or cure. Research is exploring immune, metabolic, and neurological mechanisms.
Clinical trials are advancing new treatments for myalgic encephalomyelitis. Currently, 100 studies are recruiting a combined 1,435,967 participants across the United States. Research is being conducted by 89 organizations including ClinLogic LLC, University of Southern California, Stanford University and 86 others.
2026 Myalgic Encephalomyelitis Research Landscape
As of July 2026, the myalgic encephalomyelitis clinical trial landscape includes 100 actively recruiting studies across 199 cities in the United States. These studies are collectively seeking 1,435,967 participants, with an average enrollment target of 14,360 per study.
The research spans multiple phases of development: 26 studies are in PHASE3, 18 studies are in NA, 7 studies are in PHASE2, 5 studies are in PHASE4. The presence of Phase 3 trials indicates that some myalgic encephalomyelitis treatments are in late-stage testing and may be approaching regulatory review.
Research is being led by 89 different organizations, including ClinLogic LLC, University of Southern California, Stanford University, Simons Searchlight, Mayo Clinic, and 84 others. The large number of sponsors reflects significant research interest and investment in myalgic encephalomyelitis treatment advancement.
Geographically, myalgic encephalomyelitis trials are most concentrated in Chicago, Illinois (14 trials); Boston, Massachusetts (13 trials); Los Angeles, California (13 trials); Bethesda, Maryland (11 trials); Birmingham, Alabama (10 trials) and 7 other cities.
Featured Myalgic Encephalomyelitis Studies
Highlighted recruiting studies for myalgic encephalomyelitis, selected by enrollment size and research scope.
Reduction of Adverse Drug Events and Readmissions
Pharmocogenomic test assessment in the medication regimen and disease management for patients under drugs known with genetic variation.
Alzheimer Prevention Trials (APT) Webstudy
The goal of the Alzheimer Prevention Trials (APT) Webstudy is to accelerate enrollment for Alzheimer's disease (AD) clinical trials by identifying and tracking individuals who may be at higher risk for developing AD dementia.
Implementing Scalable, PAtient-centered, Team-based, Technology-enabled Care for Adults With Type 2 Diabetes (iPATH)
Sixteen institutions will be selected from a HRSA uniform data system and have data collected for up to 3 years. Eight institutions will begin the iPATH practice transformation during year one, the other eight institutions will begin iPATH in year two. FQHC administrators, clinicians and staff will be enrolled to participate in the iPATH transformation in their clinic and will participate in quali...
Frequently Asked Questions About Myalgic Encephalomyelitis Clinical Trials
Are there myalgic encephalomyelitis clinical trials near me?
Yes, there are 100 myalgic encephalomyelitis clinical trials currently recruiting across 199+ cities in the United States, including Chicago, Illinois; Boston, Massachusetts; Los Angeles, California. Browse the studies above to find one at a location convenient for you.
How do I join a myalgic encephalomyelitis clinical trial?
To join a myalgic encephalomyelitis clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are myalgic encephalomyelitis clinical trials free?
Yes, participation in myalgic encephalomyelitis clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of myalgic encephalomyelitis treatments are being studied?
Current myalgic encephalomyelitis clinical trials are testing a range of approaches across PHASE3 (26 studies), NA (18 studies), PHASE2 (7 studies), PHASE4 (5 studies). These include new drugs, combination therapies, medical devices, and other interventions sponsored by 89 research organizations.
Is it safe to participate in myalgic encephalomyelitis clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated July 16, 2026 from ClinicalTrials.gov
About This Data
Data: ClinicalTrials.gov · Source of record for eligibility and locations
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated July 16, 2026 · Data from ClinicalTrials.gov